根治性前列腺切除术或观察等待联合或不联合雄激素剥夺治疗后的生活质量:SPCG-4随机试验
研究向SPCG-4试验中仍存活的400例随机分至根治性前列腺切除术或观察等待的男性及281例对照组发放问卷,评估雄激素剥夺治疗对生活质量、临床检查时担忧及所获信息的影响。观察等待组未用雄激素剥夺治疗者高生活质量比例与无前列腺癌对照组相当,而观察等待组使用雄激素剥夺治疗者所有心理参数评分最低且所获疾病信息最少。
要点
- 观察等待组未用雄激素剥夺治疗者高生活质量44%,与对照组45%相当。
- 观察等待组使用雄激素剥夺治疗者高生活质量20%,为各组最低。
- 使用雄激素剥夺治疗者临床检查时担忧程度显著高于未使用者。
核心结论
- 观察等待组未使用雄激素剥夺治疗的男性报告的高生活质量与无前列腺癌男性相当。
- 观察等待组使用雄激素剥夺治疗与所有心理参数最低评分相关,且这些男性报告对前列腺癌及其后果了解最少。
研究设计与样本
- 研究向SPCG-4试验中随机分至根治性前列腺切除术或观察等待且仍存活的400/695例男性及281例对照组男性发放研究专用问卷。
- 采用对数二项回归估计组间风险比较的相对风险及95%置信区间。
主要发现
- SPCG-4男性中位随访12.2年,中位年龄77.0岁;根治性前列腺切除术组26%、观察等待组40%接受雄激素剥夺治疗。
- 未使用雄激素剥夺治疗者高生活质量比例:根治性前列腺切除术组36%,观察等待组44%,对照组45%。
- 使用雄激素剥夺治疗者高生活质量比例:根治性前列腺切除术组30%,观察等待组20%。
- 使用雄激素剥夺治疗者中,观察等待组所获疾病信息显著少于根治性前列腺切除术组;报告未获或仅获少量前列腺癌信息的比例在根治性前列腺切除术组为17%、观察等待组为39%(相对风险0.44,95%CI 0.22-0.89)。
- 临床检查时,使用雄激素剥夺治疗的男性无论研究分组,担忧程度均显著高于未使用雄激素剥夺治疗者。
局限性
- 缺乏纵向数据。
- 根治性前列腺切除术组接受雄激素剥夺治疗的男性数量少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Men with prostate cancer experience adjuvant androgen deprivation therapy (ADT) differently. OBJECTIVE: To evaluate the effect of ADT on quality of life (QoL), patients' experience of clinical check-ups, and differences in cancer information as explanatory factors. DESIGN, SETTING, AND PARTICIPANTS: A study-specific questionnaire was sent to all men randomized in the SPCG-4 trial to radical prostatectomy (RP) or watchful waiting (WW) still alive (400/695) and a control group of 281 men. INTERVENTION: ADT. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Self-assessed QoL, worry at clinical check-ups, and amount of information received. Estimated relative risks with associated 95% confidence intervals (CI) for risk comparisons between groups using a log-binomial regression. RESULTS AND LIMITATIONS: The SPCG-4 men had median follow-up of 12.2 yr and median age of 77.0 yr; 26% in the RP group and 40% in the WW group received ADT treatment. High QoL for men without ADT was 36% for the RP group, 44% for the WW group, and 45% for the control group. High QoL for men with ADT was 30% for the RP group and 20% for the WW group. Among men with ADT, those in the WW group received significantly less information about the disease than men in the RP group. Receiving no or little information about prostate cancer was reported by 17% of patients in the RP group and 39% in the WW group among men receiving ADT (relative risk 0.44, 95% CI 0.22-0.89). At clinical check-ups, men treated with ADT had significantly higher levels of worry, regardless of study group, than men without ADT. Limitations include the lack of longitudinal data and a low number of men receiving ADT in the RP group. CONCLUSIONS: Men on WW without ADT reported high QoL comparable to that for men without prostate cancer. ADT treatment in the WW group was associated with the lowest scores for all psychological parameters, and these men reported that they were least informed about prostate cancer and its consequences. PATIENT SUMMARY: Good communication and information from caregivers are associated with less negative psychological effects at prostate cancer progression.
引用
- Johansson E, Steineck G, Holmberg L, et al. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial. Eur Urol Oncol. 2018. PMID: 31100237. doi:10.1016/j.euo.2018.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。